Inhibition of restenosis in femoropopliteal arteries. Paclitaxel-coated versus uncoated balloon: Femoral paclitaxel randomized pilot trial

Circulation

Volumn 118, Issue 13, 2008, Pages 1358-1365

  Werk, Michael ^a   Langner, Soenke ^b   Reinkensmeier, Bianka ^a   Boettcher, Hans Frank ^a   Tepe, Gunnar ^c   Dietz, Ulrich ^d   Hosten, Norbert ^b   Hamm, Bernd ^a   Speck, Ulrich ^a   Ricke, Jens ^e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^e OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Angioplasty; Balloon; Catheters; Claudication; Restenosis

Indexed keywords

PACLITAXEL; BIOMATERIAL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BALLOON CATHETER; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; EMBOLISM; FEMALE; FEMORAL ARTERY; HUMAN; INTERMETHOD COMPARISON; LEG REVASCULARIZATION; MALE; MULTICENTER STUDY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RESTENOSIS; TREATMENT OUTCOME; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FOLLOW UP; METHODOLOGY; PERIPHERAL VASCULAR DISEASE; PILOT STUDY; RECURRENT DISEASE;

AGED; ANGIOPLASTY, BALLOON; COATED MATERIALS, BIOCOMPATIBLE; DISEASE-FREE SURVIVAL; DRUG DELIVERY SYSTEMS; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; PACLITAXEL; PERIPHERAL VASCULAR DISEASES; PILOT PROJECTS; POPLITEAL ARTERY; RECURRENCE; TREATMENT OUTCOME;

EID: 54049125687     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.735985     Document Type: Article

References (23)

1. Dormandy JA, Rutherford B. Management of peripheral arterial disease (PAD). J Vasc Surg. 2000;31:S1-S296.
2. Johnston KW. Femoral and popliteal arteries: reanalysis of results of balloon angioplasty. Radiology. 1992;183:767-771.
3. Minar E, Pokrajac B, Maca T, Ahmadi R, Fellner C, Mittlbock M, Seitz W, Wolfram R, Potter R. Endovascular brachytherapy for therapy of restenosis after femoropopliteal angioplasty: results of a prospective randomized study. Circulation. 2000;102:2694-2699.
4. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. Transatlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1-S296.
5. Lincoff AM, Topol EJ, Ellis SG. Local drug delivery for the prevention of restenosis: fact, fancy, and future. Circulation. 1994;90:2070-2082.
6. Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A, Wiesinger B, Hak JB, Tielemans H, Ziemer G, Cristea E, Lansky A, Bérégi JP. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106: 1505-1509.
7. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-338.
8. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Küttner A, Wild DH, Brehm BR, Riessen R, Köveker G, Karsch KR. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636-645.
9. Scheller B, Speck U, Romeike B, Schmitt A, Sovak M, Böhm M, Stoll HP. Contrast media as carriers for local drug delivery: successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J. 2003;24:1462-1467.
10. Scheller B, Speck U, Schmitt A, Böhm M, Nickenig G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol. 2003;42:1415-1420.
11. Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation. 2004;110:810-814.
12. Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M, Hamm B. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology. 2006;240:411-418.
13. Albrecht T, Speck U, Beier C, Wolf KJ, Böhm M, Scheller B. Reduction of in-stent restenosis after percutaneous transluminal angioplasty of peripheral porcine arteries by local peri-interventional administration of Paclitaxel. Invest Radiol. 2007;42:579-585.
14. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006;355:2113-2124.
15. Krueger K, Zaehringer M, Bendel M, Stuetzer H, Strohe D, Nolte M, Wittig D, Mueller RP, Lackner K. De novo femoropopliteal stenoses: endovascular gamma irradiation following angioplasty: angiographic and clinical follow-up in a prospective randomized controlled trial. Radiology. 2004;231:546-554.
16. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W, Schlager O, Cejna M, Lammer J, Minar E. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888.
17. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, Loewe C, Cejna M, Lammer J, Minar E. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745-2749.
18. Mauri L, Orav EJ, Candia SC, Cutlip DE, Kuntz RE. Robustness of late lumen loss in discriminating drug eluting stents across variable observational and randomized trials. Circulation. 2005;112:2833-2839.
19. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Küttner A, Wild DH, Brehm BR, Riessen R, Köveker G, Karsch KR. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation. 1997;96:636-645.
20. Speck U, Scheller B, Abramjuk C, Grossmann S, Mahnkopf D, Simon O. Inhibition of restenosis in stented porcine coronary arteries: uptake of paclitaxel from angiographic contrast media. Invest Radiol. 2004;39: 182-186.
21. Duda SH, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V, Tielbeek A, Anderson J, Wiesinger B, Tepe G, Lansky A, Jaff MR, Mudde C, Tielemans H, Beregi JP. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13: 701-710.
22. Scheller B, Speck U, Böhm M. Prevention of restenosis: is angioplasty the answer? Heart. 2007;93:539-541.
23. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi J-P, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699.